Globus Medical (GMED) Tops Q1 EPS by 2c, Raises FY Revenue Guidance

Globus Medical (NYSE: GMED) reported Q1 EPS of $0.26, $0.02 better than the analyst estimate of $0.24. Revenue for the quarter came in at $131.6 million versus the consensus estimate of $122.3 million.

Globus Medical sees FY2015 EPS of $1.02, versus the consensus of $1.02. Globus Medical sees FY2015 revenue of $514 million, versus the consensus of $511.64 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Virax Biolabs announces 1-for-25 reverse stock split on Nasdaq
• Benchmark Reiterates Hold Rating on Old Dominion Freight Line (ODFL) as 'Quality Largely Priced in'